Literature DB >> 21476915

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

Naim Alkhouri1, Christine Carter-Kent, Ariel E Feldstein.   

Abstract

Pathological increases in cell death in the liver as well as in peripheral tissues has emerged as an important mechanism involved in the development and progression of nonalcoholic fatty liver disease (NAFLD). An increase in hepatocyte cell death by apoptosis is typically present in patients with NAFLD and in experimental models of steatohepatitis, while an increase in adipocyte cell death in visceral adipose tissue may be an important mechanism triggering insulin resistance and hepatic steatosis. The two fundamental pathways of apoptosis, the extrinsic (death receptor-mediated) and intrinsic (organelle-initiated) pathways, are both involved. This article summarizes the current knowledge related to the distinct molecular and biochemical pathways of cell death involved in NAFLD pathogenesis. In particular, it will highlight the efforts for the development of both novel diagnostic and therapeutic strategies based on this knowledge.

Entities:  

Mesh:

Year:  2011        PMID: 21476915      PMCID: PMC3119461          DOI: 10.1586/egh.11.6

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  120 in total

Review 1.  The unfolded protein response.

Authors:  Chuan Yin Liu; Randal J Kaufman
Journal:  J Cell Sci       Date:  2003-05-15       Impact factor: 5.285

2.  CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis.

Authors:  Sophie C Cazanave; Nafisa A Elmi; Yuko Akazawa; Steven F Bronk; Justin L Mott; Gregory J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

Review 3.  Molecular mechanisms of caspase regulation during apoptosis.

Authors:  Stefan J Riedl; Yigong Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

Review 4.  Dying a thousand deaths: redundant pathways from different organelles to apoptosis and necrosis.

Authors:  John J Lemasters
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

Review 5.  Apoptosis in alcoholic and nonalcoholic steatohepatitis.

Authors:  Ariel E Feldstein; Gregory J Gores
Journal:  Front Biosci       Date:  2005-09-01

Review 6.  Mechanisms of disease progression in nonalcoholic fatty liver disease.

Authors:  Janice Jou; Steve S Choi; Anna Mae Diehl
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

7.  Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.

Authors:  Ali Canbay; Hajime Higuchi; Steven F Bronk; Makiko Taniai; Tom J Sebo; Gregory J Gores
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

8.  Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Authors:  Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

9.  First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes.

Authors:  K L Valentino; M Gutierrez; R Sanchez; M J Winship; D A Shapiro
Journal:  Int J Clin Pharmacol Ther       Date:  2003-10       Impact factor: 1.366

10.  Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.

Authors:  Ariel E Feldstein; Anna Wieckowska; A Rocio Lopez; Yao-Chang Liu; Nizar N Zein; Arthur J McCullough
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

View more
  84 in total

1.  Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD.

Authors:  Naim Alkhouri; Arthur J McCullough
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

Review 2.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

3.  Function of inhibitor of Bruton's tyrosine kinase isoform α (IBTKα) in nonalcoholic steatohepatitis links autophagy and the unfolded protein response.

Authors:  Jeffrey A Willy; Sara K Young; Amber L Mosley; Samer Gawrieh; James L Stevens; Howard C Masuoka; Ronald C Wek
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

4.  Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.

Authors:  A Wree; C D Johnson; J Font-Burgada; A Eguchi; D Povero; M Karin; A E Feldstein
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

5.  Circulating Soluble Fas and Fas Ligand Levels Are Elevated in Children with Nonalcoholic Steatohepatitis.

Authors:  Naim Alkhouri; Anna Alisi; Vera Okwu; Ammar Matloob; Federica Ferrari; Annalisa Crudele; Rita De Vito; Rocio Lopez; Ariel E Feldstein; Valerio Nobili
Journal:  Dig Dis Sci       Date:  2015-03-13       Impact factor: 3.199

6.  The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.

Authors:  April D Lake; Petr Novak; Rhiannon N Hardwick; Brieanna Flores-Keown; Fei Zhao; Walter T Klimecki; Nathan J Cherrington
Journal:  Toxicol Sci       Date:  2013-10-04       Impact factor: 4.849

7.  Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development.

Authors:  Yan Li; Jie Hai; Lake Li; Xuehui Chen; Hua Peng; Meng Cao; Qinggui Zhang
Journal:  Endocrine       Date:  2012-07-29       Impact factor: 3.633

8.  IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans.

Authors:  Fawaz Alzaid; Floriane Lagadec; Miguel Albuquerque; Raphaëlle Ballaire; Lucie Orliaguet; Isabelle Hainault; Corinne Blugeon; Sophie Lemoine; Agnès Lehuen; David G Saliba; Irina A Udalova; Valérie Paradis; Fabienne Foufelle; Nicolas Venteclef
Journal:  JCI Insight       Date:  2016-12-08

Review 9.  Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?

Authors:  Naim Alkhouri; Ariel E Feldstein
Journal:  Metabolism       Date:  2016-02-02       Impact factor: 8.694

Review 10.  Developmental origins of nonalcoholic fatty liver disease.

Authors:  David E Brumbaugh; Jacob E Friedman
Journal:  Pediatr Res       Date:  2013-11-05       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.